| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $91K | — | — |
| R&D Expense | $293K | +221.6% | -35.2% |
| SG&A Expense | $3.5M | +74.2% | +332.5% |
| Pre-tax Income | -$3.7M | -86.5% | -152.8% |
| Net Income | -$3.7M | -86.5% | -152.8% |
| EPS (Basic) | -$0.12 | -71.4% | -140.0% |
| EPS (Diluted) | -$0.12 | -71.4% | -140.0% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $89K | — | — |
| Current Assets | $897K | -88.4% | — |
| Total Assets | $8.5M | +5.0% | — |
| Current Liabilities | $4.0M | +96.0% | — |
| Total Liabilities | $4.0M | +95.5% | — |
| Stockholders' Equity | $4.5M | -25.6% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | -595.0% | — |
| Investing Cash Flow | -$48K | -1588.8% | — |
| Financing Cash Flow | $4.3M | +504.5% | — |